Novartis AG (NVSEF) stock

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Novartis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?